Geode Capital Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $9.63K | Hold |
|
|||||
|
2023
Q1 | $17.2K | Hold |
|
|||||
|
2022
Q4 | $15K | Hold |
|
|||||
|
2022
Q3 | $21K | Hold |
|
|||||
|
2022
Q2 | $22K | Hold |
|
|||||
|
2022
Q1 | $63K | Hold |
|
|||||
|
2021
Q4 | $65K | Sell |
|
|||||
|
2021
Q3 | $104K | Buy |
|
|||||
|
2021
Q2 | $65K | Sell |
|
|||||
|
2021
Q1 | $672K | Buy |
|
|||||
|
2020
Q4 | $743K | Buy |
|
|||||
|
2020
Q3 | $731K | Buy |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $97K | Buy |
|
|||||
|
2019
Q4 | $57K | Hold |
|
|||||
|
2019
Q3 | $48K | Sell |
|
|||||
|
2019
Q2 | $39K | Sell |
|
|||||
|
2019
Q1 | $294K | Buy |
|
|||||
|
2018
Q4 | $175K | Buy |
|
|||||
|
2018
Q3 | $297K | Buy |
|
|||||
|
2018
Q2 | $368K | Buy |
|
|||||
|
2018
Q1 | $382K | Buy |
|
|||||
|
2017
Q4 | $294K | Buy |
|
|||||
|
2017
Q3 | $310K | Buy |
|
|||||
|
2017
Q2 | $326K | Buy |
|
|||||
|
2017
Q1 | $77K | Buy |
|
|||||
|
2016
Q4 | $55K | Buy |
|
|||||
|
2016
Q3 | $46K | Buy |
|
|||||
|
2016
Q2 | $47K | Hold |
|
|||||
|
2016
Q1 | $34 | Sell |
|
|||||
|
2015
Q4 | $46K | Buy |
|